• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rad50 通过 NF-κB 激活促进卵巢癌进展。

Rad50 promotes ovarian cancer progression through NF-κB activation.

机构信息

Key Laboratory of Experimental Teratology, Ministry of Education, Department of Obstetrics and Gynecology, Qilu Hospital, Department of Cell Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.

Department of Obstetrics & Gynecology, Jinhua Hospital of Zhejiang University, Jinhua, China.

出版信息

J Cell Mol Med. 2021 Dec;25(23):10961-10972. doi: 10.1111/jcmm.17017. Epub 2021 Nov 3.

DOI:10.1111/jcmm.17017
PMID:34734468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8642684/
Abstract

Rad50 is a component of MRN (Mre11-Rad50-Nbs1), which participates in DNA double-strand break repair and DNA-damage checkpoint activation. Here, we sought to investigate the clinical and functional significance of Rad50 in high-grade serous ovarian cancer (HGSOC). We found that Rad50 was frequently upregulated in HGSOCs and enhanced Rad50 expression inversely correlated with patient survival. In addition, ectopic expression of Rad50 promoted proliferation/invasion and induced EMT of ovarian cancer cells, whereas knockdown of Rad50 led to decreased aggressive behaviors. Mechanistic investigations revealed that Rad50 induced aggressiveness in HGSOC via activation of NF-κB signaling pathway. Moreover, we identified CARD9 as an interacting protein of Rad50 in ovarian cancer cells and the activation of NF-κB pathway by Rad50 is CARD9 dependent. Our findings provide evidence that Rad50 exhibits oncogenic property via NF-κB activation in HGSOC.

摘要

Rad50 是 MRN(Mre11-Rad50-Nbs1)的一个组成部分,参与 DNA 双链断裂修复和 DNA 损伤检查点激活。在这里,我们试图研究 Rad50 在高级别浆液性卵巢癌(HGSOC)中的临床和功能意义。我们发现 Rad50 在 HGSOC 中经常上调,并且增强的 Rad50 表达与患者生存呈负相关。此外,Rad50 的异位表达促进了卵巢癌细胞的增殖/侵袭,并诱导了 EMT,而 Rad50 的敲低导致侵袭性行为减少。机制研究表明,Rad50 通过激活 NF-κB 信号通路诱导 HGSOC 的侵袭性。此外,我们在卵巢癌细胞中鉴定出 CARD9 是 Rad50 的相互作用蛋白,并且 Rad50 对 NF-κB 通路的激活依赖于 CARD9。我们的研究结果表明,Rad50 通过在 HGSOC 中激活 NF-κB 表现出致癌特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/ffb47dcd455a/JCMM-25-10961-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/3e445e81b3f4/JCMM-25-10961-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/b01af9726ab2/JCMM-25-10961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/28024e4d5514/JCMM-25-10961-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/c3fbc4a0c3c6/JCMM-25-10961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/c2d742c44ed9/JCMM-25-10961-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/ffb47dcd455a/JCMM-25-10961-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/3e445e81b3f4/JCMM-25-10961-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/b01af9726ab2/JCMM-25-10961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/28024e4d5514/JCMM-25-10961-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/c3fbc4a0c3c6/JCMM-25-10961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/c2d742c44ed9/JCMM-25-10961-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb4e/8642684/ffb47dcd455a/JCMM-25-10961-g006.jpg

相似文献

1
Rad50 promotes ovarian cancer progression through NF-κB activation.Rad50 通过 NF-κB 激活促进卵巢癌进展。
J Cell Mol Med. 2021 Dec;25(23):10961-10972. doi: 10.1111/jcmm.17017. Epub 2021 Nov 3.
2
Ataxia telangiectasia-mutated (ATM) kinase activity is regulated by ATP-driven conformational changes in the Mre11/Rad50/Nbs1 (MRN) complex.共济失调毛细血管扩张症突变(ATM)激酶活性受 Mre11/Rad50/Nbs1(MRN)复合物中 ATP 驱动的构象变化调节。
J Biol Chem. 2013 May 3;288(18):12840-51. doi: 10.1074/jbc.M113.460378. Epub 2013 Mar 22.
3
ATP puts the brake on DNA double-strand break repair: a new study shows that ATP switches the Mre11-Rad50-Nbs1 repair factor between signaling and processing of DNA ends.ATP对DNA双链断裂修复起到制动作用:一项新研究表明,ATP可使Mre11-Rad50-Nbs1修复因子在DNA末端信号传导和处理之间进行转换。
Bioessays. 2014 Dec;36(12):1170-8. doi: 10.1002/bies.201400102. Epub 2014 Sep 11.
4
Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer.ATMIN-DYNLL1-MRN 轴在浆液性卵巢癌的进展和侵袭中的作用。
Biochem Biophys Res Commun. 2021 Sep 17;570:74-81. doi: 10.1016/j.bbrc.2021.07.004. Epub 2021 Jul 14.
5
Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.在结肠癌细胞中,共济失调毛细血管扩张症突变基因(ATM)对依赖复制的DNA双链断裂作出反应时,Mre11依赖的Chk2激活存在缺陷。
J Biol Chem. 2006 Oct 13;281(41):30814-23. doi: 10.1074/jbc.M603747200. Epub 2006 Aug 10.
6
Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template.Mre11-Rad50-Nbs1是一个连接DNA修复机制、双链断裂信号传导和染色质模板的关键复合物。
Biochem Cell Biol. 2007 Aug;85(4):509-20. doi: 10.1139/O07-069.
7
Rad50 zinc hook is important for the Mre11 complex to bind chromosomal DNA double-stranded breaks and initiate various DNA damage responses.Rad50 锌指对于 Mre11 复合物结合染色体 DNA 双链断裂并启动各种 DNA 损伤反应非常重要。
J Biol Chem. 2012 Sep 14;287(38):31747-56. doi: 10.1074/jbc.M112.384750. Epub 2012 Jul 25.
8
Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.在低级别上皮性卵巢癌中,MRE11-RAD50-NBS1(MRN)复合物检测缺失频繁出现。
BMC Cancer. 2017 Jan 10;17(1):44. doi: 10.1186/s12885-016-3026-2.
9
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.乳腺癌风险与编码DNA双链断裂修复Mre11/Rad50/Nbs1复合体的基因相关。
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2024-32. doi: 10.1158/1055-9965.EPI-07-0116.
10
Activation and regulation of ATM kinase activity in response to DNA double-strand breaks.响应DNA双链断裂时ATM激酶活性的激活与调控。
Oncogene. 2007 Dec 10;26(56):7741-8. doi: 10.1038/sj.onc.1210872.

引用本文的文献

1
When DNA-damage responses meet innate and adaptive immunity.当 DNA 损伤反应遇到先天免疫和适应性免疫。
Cell Mol Life Sci. 2024 Apr 17;81(1):185. doi: 10.1007/s00018-024-05214-2.
2
Drug resistance in ovarian cancer: from mechanism to clinical trial.卵巢癌的耐药性:从机制到临床试验。
Mol Cancer. 2024 Mar 28;23(1):66. doi: 10.1186/s12943-024-01967-3.
3
The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond.MRN复合体的多面性:在髓母细胞瘤及其他方面的作用

本文引用的文献

1
ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.ID1 通过 STAT3/ATF6 介导的自噬诱导赋予癌细胞化疗耐药性。
Cell Death Dis. 2020 Feb 20;11(2):137. doi: 10.1038/s41419-020-2327-1.
2
ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis.表皮生长因子受体 3 诱导的弗林蛋白酶通过 IGF1R/STAT3 信号通路促进卵巢癌的进展和转移。
Oncogene. 2020 Apr;39(14):2921-2933. doi: 10.1038/s41388-020-1194-7. Epub 2020 Feb 6.
3
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity.
Cancers (Basel). 2023 Jul 13;15(14):3599. doi: 10.3390/cancers15143599.
4
Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients.同源重组 mRNA(RAD21、RAD50 和 BARD1)在 ERBB2 低表达膀胱癌患者中具有潜在的不良预后作用。
Sci Rep. 2023 Jul 20;13(1):11738. doi: 10.1038/s41598-023-38923-y.
5
CARD9 contributes to ovarian cancer cell proliferation, cycle arrest, and cisplatin sensitivity.CARD9 促进卵巢癌细胞增殖、周期阻滞和铂类药物敏感性。
BMC Mol Cell Biol. 2022 Nov 28;23(1):49. doi: 10.1186/s12860-022-00447-0.
6
Mycobiota and C-Type Lectin Receptors in Cancers: Know thy Neighbors.癌症中的真菌群落与C型凝集素受体:了解你的邻居。
Front Microbiol. 2022 Jul 13;13:946995. doi: 10.3389/fmicb.2022.946995. eCollection 2022.
AZD7648 是一种有效的、选择性的 DNA-PK 抑制剂,能够增强放射治疗、化疗和奥拉帕利的疗效。
Nat Commun. 2019 Nov 7;10(1):5065. doi: 10.1038/s41467-019-12836-9.
4
PARP inhibitor pick-me-up.
Nat Rev Drug Discov. 2019 Oct;18(11):814. doi: 10.1038/d41573-019-00174-w.
5
C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex.C1QBP 通过稳定 MRE11 并控制 MRE11/RAD50/NBS1 复合物的组装和激活来促进同源重组。
Mol Cell. 2019 Sep 19;75(6):1299-1314.e6. doi: 10.1016/j.molcel.2019.06.023. Epub 2019 Jul 25.
6
A decade of clinical development of PARP inhibitors in perspective.PARP 抑制剂十年临床开发透视。
Ann Oncol. 2019 Sep 1;30(9):1437-1447. doi: 10.1093/annonc/mdz192.
7
The ATP-bound conformation of the Mre11-Rad50 complex is essential for Tel1/ATM activation.Mre11-Rad50 复合物的 ATP 结合构象对于 Tel1/ATM 的激活是必需的。
Nucleic Acids Res. 2019 Apr 23;47(7):3550-3567. doi: 10.1093/nar/gkz038.
8
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.CRISPR 筛选鉴定基因组核糖核苷酸为 PARP 捕获损伤的来源。
Nature. 2018 Jul;559(7713):285-289. doi: 10.1038/s41586-018-0291-z. Epub 2018 Jul 4.
9
Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer.氧化应激增加介导了 PARP 抑制在卵巢癌中的抗肿瘤作用。
Redox Biol. 2018 Jul;17:99-111. doi: 10.1016/j.redox.2018.03.016. Epub 2018 Mar 30.
10
Targeting RAD50 increases sensitivity to radiotherapy in colorectal cancer cells.靶向 RAD50 可提高结直肠癌细胞对放疗的敏感性。
Neoplasma. 2018;65(1):75-80. doi: 10.4149/neo_2018_170219N128.